Effects and Prognostic Factors of Intensive Pulse Light Treatment for Meibomian Gland Dysfunction

NACompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

April 18, 2019

Primary Completion Date

February 18, 2020

Study Completion Date

April 10, 2020

Conditions
Meibomian Gland Dysfunction
Interventions
DEVICE

Intense Pulsed Light (IPL)

IPL therapy will be performed with the M22® (Lumenis, Dreieich, Germany). IPL treatment is going to be administered to the skin below the lower eyelid. Before treatment, the eyes will be protected with opaque goggles. Ultrasound gel is going to be applied to the patient's face from tragus to tragus including the nose in order to conduct the light, help to spread the energy evenly, and provide a degree of protection. The intensity of the IPL treatment will range from 9.8J/cm2 to 13J/cm2 according to Fitzpatrick Skin Type Grading.

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT03950115 - Effects and Prognostic Factors of Intensive Pulse Light Treatment for Meibomian Gland Dysfunction | Biotech Hunter | Biotech Hunter